Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 3:11:119.
doi: 10.1186/1475-2840-11-119.

Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients

Affiliations

Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients

Henrik Reinhard et al. Cardiovasc Diabetol. .

Abstract

Elevated plasma N-terminal (NT)-proBNP from the heart as well as white matter hyperintensities (WMH) in the brain predict cardiovascular (CV) mortality in the general population. The cause of poor prognosis associated with elevated P-NT-proBNP is not known but WMH precede strokes in high risk populations. We assessed the association between P-NT-proBNP and WMH or brain atrophy measured with magnetic resonance imaging (MRI) in type 2 diabetic patients, and age-matched controls.

Methods and results: We measured P-NT-proBNP(ng/l) in 20 diabetic patients without prior stroke but with(n=10) or without(n=10) asymptomatic coronary artery disease(CAD) in order to include patients with a wide-ranging CV risk profile. All patients and 26 controls had a 3D MRI and brain volumes(ml) with WMH and brain parenchymal fraction(BPF), an indicator of brain atrophy, were determined.P-NT-proBNP was associated with WMH in linear regression analysis adjusted for CV risk factors(r=0.94, p=0.001) and with BPF in univariate analysis(r=0.57, p=0.009). Patients divided into groups of increased P-NT-proBNP levels were paralleled with increased WMH volumes(geometric mean[SD];(2.86[5.11] ml and 0.76[2.49] ml compared to patients with low P-NT-proBNP 0.20[2.28] ml, p=0.003)) and also when adjusted for age, sex and presence of CAD(p=0.017). The association was strengthened by CV risk factors and we did not find a common heart or brain specific driver of both P-NT-proBNP and WMH. Patients and particular patients with CAD had higher WMH, however no longer after adjustment for age and sex.

Conclusion: P-NT-proBNP was associated with WMH in type 2 diabetic patients, suggesting a linkage between heart and brain disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Univariate linear regression analysis with the logarithm of plasma NT-proBNP (ng/l) in relation to the logarithm of white matter hyperintensities in 20 patients with type 2 diabetes.
Figure 2
Figure 2
A scatter plot correlation, showing white matter hyperintensities in 20 patients with type 2 diabetes and with low, intermediate and high plasma NT-proBNP levels (tertile values), respectively, (horizontal bar is geometric mean among the groups, p = 0.003).

References

    1. Gerstein HC, Mann JF, Yi Q. et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421–426. doi: 10.1001/jama.286.4.421. - DOI - PubMed
    1. Gaede P, Lund-Andersen H, Parving H-H. et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–591. doi: 10.1056/NEJMoa0706245. - DOI - PubMed
    1. Wang TJ, Larson MG, Levy D. et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350(7):655–663. doi: 10.1056/NEJMoa031994. - DOI - PubMed
    1. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J. 2010;341:c3666. doi: 10.1136/bmj.c3666. - DOI - PMC - PubMed
    1. Tarnow L, Gall M-A, Hansen BV. et al. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes. Diabetologia. 2006;49:2256–2262. doi: 10.1007/s00125-006-0359-4. - DOI - PubMed

MeSH terms